Committee tables LD 18‑47 after wide-ranging debate on testing, 'high‑potency' definition and packaging
The committee paused consideration of LD 18‑47 (testing and packaging for medical and adult‑use cannabis) and asked the sponsor and stakeholders to draft a consensus amendment after contested debate over whether to define 'high potency' in the medical program as >10 mg THC per serving and require blister packaging and a special symbol.
The full story
The Joint Standing Committee on Veterans and Legal Affairs tabled LD 18‑47 after members and stakeholders debated mandatory testing frameworks and a newly proposed definition and packaging rules for 'high‑potency' medical cannabis products.
Sign up to keep reading.
Your free newsletter brings you what your city council, county, and school board discussed and decided.
Keep reading for free
Create a free account to finish this story and see the video, transcript and key details.
Continue with GoogleContinue with emailAlready have an account? Log in